MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 67 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,074 | +111.0% | 46,722 | +484.4% | 0.00% | – |
| Q2 2023 | $2,878 | +28680.0% | 7,995 | -62.4% | 0.00% | – |
| Q1 2023 | $10 | +25.0% | 21,255 | +31.0% | 0.00% | – |
| Q4 2022 | $8 | -99.9% | 16,231 | -16.1% | 0.00% | – |
| Q3 2022 | $12,000 | +140.0% | 19,349 | +245.1% | 0.00% | – |
| Q1 2022 | $5,000 | -91.7% | 5,607 | -87.8% | 0.00% | -100.0% |
| Q3 2021 | $60,000 | -27.7% | 45,936 | -41.9% | 0.00% | +100.0% |
| Q1 2021 | $83,000 | +730.0% | 79,023 | +965.9% | 0.00% | – |
| Q4 2020 | $10,000 | – | 7,414 | +7314.0% | 0.00% | – |
| Q3 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 100 | -98.2% | 0.00% | – |
| Q2 2018 | $2,000 | -92.0% | 5,529 | -73.9% | 0.00% | -100.0% |
| Q4 2017 | $25,000 | – | 21,181 | +264662.5% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 8 | -99.9% | 0.00% | -100.0% |
| Q2 2017 | $22,000 | – | 13,260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COURAGE CAPITAL MANAGEMENT LLC | 1,000,000 | $804,000 | 0.77% |
| Sargent Investment Group, LLC | 3,643,979 | $2,931,000 | 0.74% |
| Arkadios Wealth Advisors | 1,399,000 | $1,125,000 | 0.15% |
| Kingsbury Capital Investment Advisors LLC | 119,949 | $96,000 | 0.11% |
| JTC Employer Solutions Trustee Ltd | 775,000 | $632,000 | 0.07% |
| Platform Technology Partners | 142,410 | $115,000 | 0.06% |
| Main Street Financial Solutions, LLC | 400,826 | $322,000 | 0.05% |
| National Wealth Management Group, LLC | 32,100 | $25,821 | 0.02% |
| STALEY CAPITAL ADVISERS INC | 600,000 | $483,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 753,391 | $606,000 | 0.01% |